{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:53:20Z","timestamp":1778172800929,"version":"3.51.4"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.reth.2022.09.001","type":"journal-article","created":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T05:16:01Z","timestamp":1664082961000},"page":"406-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Pathogenesis and potential therapeutic application of stem cells transplantation in Huntington\u2019s disease"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6625-0377","authenticated-orcid":false,"given":"Sudeepto","family":"Saha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8770-1050","authenticated-orcid":false,"given":"Manami Jayati","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman Khan","family":"Promon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0144-5875","authenticated-orcid":false,"given":"Yusha","family":"Araf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reth.2022.09.001_bib1","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","article-title":"Role of neuroinflammation in neurodegenerative diseases (Review)","volume":"13","author":"Chen","year":"2016","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.reth.2022.09.001_bib2","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jconrel.2020.11.021","article-title":"Neurodegenerative diseases and effective drug delivery: a review of challenges and novel therapeutics","volume":"330","author":"Akhtar","year":"2021","journal-title":"J\u00a0Contr Release"},{"key":"10.1016\/j.reth.2022.09.001_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.expneurol.2014.02.021","article-title":"The past, present and future of stem cell clinical trials for ALS","volume":"262","author":"Thomsen","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1016\/j.reth.2022.09.001_bib4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"T","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.reth.2022.09.001_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"V","year":"1998","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.reth.2022.09.001_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A\u00a0novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.reth.2022.09.001_bib7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/jmedgenet-2013-101796","article-title":"CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease","volume":"50","author":"S","year":"2013","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.reth.2022.09.001_bib8","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/aps.2018.11","article-title":"Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities","volume":"39","author":"H","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.reth.2022.09.001_bib9","doi-asserted-by":"crossref","first-page":"15916","DOI":"10.1074\/jbc.M511007200","article-title":"Expression and characterization of full-length human huntingtin, an elongated HEAT repeat protein","volume":"281","author":"L","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.reth.2022.09.001_bib10","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1021\/acs.jproteome.6b00991","article-title":"Post-translational modifications (PTMs), identified on endogenous huntingtin, cluster within proteolytic domains between HEAT repeats","volume":"16","author":"R","year":"2017","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.reth.2022.09.001_bib11","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1093\/hmg\/ddw234","article-title":"Huntingtin N17 domain is a reactive oxygen species sensor regulating huntingtin phosphorylation and localization","volume":"25","author":"D","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.reth.2022.09.001_bib12","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology","volume":"19","author":"G","year":"1999","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.reth.2022.09.001_bib13","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11184","article-title":"Huntingtin\u2019s spherical solenoid structure enables polyglutamine tract-dependent modulation of its structure and function","volume":"5","author":"Vijayvargia","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.reth.2022.09.001_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12035-014-8715-8","article-title":"Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective","volume":"51","author":"V","year":"2015","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.reth.2022.09.001_bib15","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin","volume":"125","author":"G","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.reth.2022.09.001_bib16","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.1221891110","article-title":"Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease","volume":"110","author":"S","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.reth.2022.09.001_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","article-title":"Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions","volume":"10","author":"Lunkes","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.reth.2022.09.001_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1471-4159.2002.00940.x","article-title":"Comparison of huntingtin proteolytic\u00a0fragments in human lymphoblast cell lines and human brain","volume":"82","author":"T","year":"2002","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.reth.2022.09.001_bib19","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1523\/JNEUROSCI.22-18-07862.2002","article-title":"Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease","volume":"22","author":"W","year":"2002","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.reth.2022.09.001_bib20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.reth.2022.09.001_bib21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/hmg\/11.17.1953","article-title":"Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses","volume":"11","author":"Sipione","year":"2002","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.reth.2022.09.001_bib22","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.reth.2022.09.001_bib23","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"S","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.reth.2022.09.001_bib24","doi-asserted-by":"crossref","first-page":"15179","DOI":"10.1073\/pnas.261400698","article-title":"Histone deacetylase inhibitors reduce polyglutamine toxicity","volume":"98","author":"M","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.reth.2022.09.001_bib25","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington\u2019s disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.reth.2022.09.001_bib26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"S","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.reth.2022.09.001_bib27","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"H","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.reth.2022.09.001_bib28","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1586\/ern.11.149","article-title":"Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders","volume":"11","author":"Jankovic","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.reth.2022.09.001_bib29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1212\/WNL.38.3.391","article-title":"Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias","volume":"38","author":"Jankovic","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.reth.2022.09.001_bib30","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM200009283431316","article-title":"Improvement of Huntington's disease with olanzapine and valproate","volume":"343","author":"Grove","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.reth.2022.09.001_bib31","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1212\/WNL.59.5.694","article-title":"Huntington's disease: a randomized, controlled trial using the NMDA-antagonist amantadine","volume":"59","author":"Metman","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.reth.2022.09.001_bib32","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1212\/01.WNL.0000068165.07883.64","article-title":"IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study","volume":"60","author":"Lucetti","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.reth.2022.09.001_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.wnf.0000240945.44370.f0","article-title":"Two years' follow-up of rivastigmine treatment in Huntington disease","volume":"30","author":"De Tommaso","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.reth.2022.09.001_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/10401239609149087","article-title":"L-Deprenyl augmentation of fluoxetine in a patient with Huntington's disease","volume":"8","author":"Patel","year":"1996","journal-title":"Ann Clin Psychiatr"},{"key":"10.1016\/j.reth.2022.09.001_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(73)93285-6","article-title":"Baclofen and lithium in Huntington's chorea","volume":"2","author":"And\u00e9n","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.reth.2022.09.001_bib36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1176\/jnp.2006.18.4.553","article-title":"Nabilone could treat chorea and irritability in Huntington's disease","volume":"18","author":"Curtis","year":"2006","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.reth.2022.09.001_bib37","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/aps.2018.11","article-title":"Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities","volume":"39","author":"Harding","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.reth.2022.09.001_bib38","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial","volume":"66","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.reth.2022.09.001_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cns.12027","article-title":"Cell therapy: the final frontier for treatment of neurological diseases","volume":"19","author":"D","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.reth.2022.09.001_bib40","article-title":"Neural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challenges","volume":"6","author":"K","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.reth.2022.09.001_bib41","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1002\/jcp.26192","article-title":"Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases","volume":"233","author":"LF","year":"2018","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.reth.2022.09.001_bib42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/stem.2747","article-title":"Concise review: the use of stem cells for understanding and treating huntington's disease","volume":"36","author":"C","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.reth.2022.09.001_bib43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/157488811795495486","article-title":"Mesenchymal stem cells neuronal differentiation ability: a real perspective for nervous system repair?","volume":"6","author":"S","year":"2011","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1016\/j.reth.2022.09.001_bib44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.trsl.2009.07.006","article-title":"Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease","volume":"155","author":"V","year":"2010","journal-title":"Transl Res"},{"key":"10.1016\/j.reth.2022.09.001_bib45","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0166-2236(00)01680-5","article-title":"Adult versus embryonic stem cells: which is the way forward?","volume":"23","author":"Svendsen","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.reth.2022.09.001_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/scrt545","article-title":"Reductions in behavioral deficits and neuropathology in the R6\/2 mouse model of Huntington's disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number","volume":"6","author":"Rossignol","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.reth.2022.09.001_bib47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbr.2010.11.006","article-title":"Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington\u2019s disease: morphological and behavioral outcomes","volume":"217","author":"Rossignol","year":"2011","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.reth.2022.09.001_bib48","first-page":"331","volume":"33","author":"Jiang","year":"2013"},{"key":"10.1016\/j.reth.2022.09.001_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/currents.RRN1183","article-title":"Transplantation of patient-derived adipose stem cells in YAC128 Huntington's disease transgenic mice","volume":"2","author":"Im","year":"2010","journal-title":"PLoS Curr"},{"key":"10.1016\/j.reth.2022.09.001_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4449","article-title":"High-efficiency motor neuron differentiation from human pluripotent stem cells and the function of Islet-1","volume":"5","author":"Qu","year":"2014","journal-title":"Nature Communications"},{"key":"10.1016\/j.reth.2022.09.001_bib51","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12015-013-9441-8","article-title":"Human pluripotent stem cell differentiation into authentic striatal projection neurons","volume":"9","author":"DC","year":"2013","journal-title":"Stem Cell Rev Reports"},{"key":"10.1016\/j.reth.2022.09.001_bib52","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3389\/fnins.2017.00628","article-title":"Induced pluripotent stem cell-derived neural stem cell transplantations reduced behavioral deficits and ameliorated neuropathological changes in YAC128 mouse model of huntington's disease","author":"Al-Gharaibeh","year":"2017","journal-title":"Front Neurosci"},{"key":"10.1016\/j.reth.2022.09.001_bib53","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/stem.1135","article-title":"Neuronal properties, in\u00a0vivo effects, and\u00a0pathology of a Huntington's disease patient-derived induced pluripotent\u00a0stem cells","volume":"30","author":"J","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.reth.2022.09.001_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/frym.2020.00032","article-title":"What are embryonic stem cells and how can they help us?","volume":"8","author":"Meshorer","year":"2020","journal-title":"Front Young Minds"},{"key":"10.1016\/j.reth.2022.09.001_bib55","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0960-9822(98)70399-9","article-title":"Generation of purified neural precursors from embryonic stem cells by lineage selection","volume":"8","author":"Li","year":"1998","journal-title":"Curr Biol"},{"key":"10.1016\/j.reth.2022.09.001_bib56","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2007.05.066","article-title":"Human embryonic stem cell-derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions","volume":"423","author":"Song","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.reth.2022.09.001_bib57","unstructured":"Neural stem cell | biology | Britannica n.d https:\/\/www.britannica.com\/science\/neural-stem-cell (Accessed April 18, 2022)."},{"key":"10.1016\/j.reth.2022.09.001_bib58","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00221-006-0689-y","article-title":"Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease","volume":"177","author":"Johann","year":"2007","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.reth.2022.09.001_bib59","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.neuro.28.051804.101459","article-title":"Adult neurogenesis in the mammalian central nervous system","volume":"28","author":"Ming","year":"2005","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.reth.2022.09.001_bib60","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/cns.12839","article-title":"Therapeutic effects of stem cells in rodent models of Huntington's disease: review and electrophysiological findings","volume":"24","author":"Holley","year":"2018","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.reth.2022.09.001_bib61","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.reth.2022.09.001_bib62","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/mt.2016.12","article-title":"Human mesenchymal stem cells genetically engineered to overexpress brain-derived neurotrophic factor improve outcomes in huntington's disease mouse models","volume":"24","author":"Pollock","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.reth.2022.09.001_bib63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","article-title":"Genetic correction of huntington's disease phenotypes in induced pluripotent stem cells","volume":"11","author":"An","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.reth.2022.09.001_bib64","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/ana.21788","article-title":"Slowed progression in models of Huntington disease by adipose stem cell transplantation","volume":"66","author":"Lee","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.reth.2022.09.001_bib65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2202-13-97","article-title":"Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6\/2 transgenic mouse model of Huntington's disease","volume":"13","author":"El-Akabawy","year":"2012","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.reth.2022.09.001_bib66","first-page":"397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"S","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.reth.2022.09.001_bib67","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.stemcr.2016.08.018","article-title":"ESC-derived BDNF-overexpressing neural progenitors differentially promote recovery in huntington's disease models by enhanced striatal differentiation","volume":"7","author":"Zimmermann","year":"2016","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.reth.2022.09.001_bib68","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.expneurol.2010.03.005","article-title":"Ex\u00a0vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease","volume":"224","author":"Ebert","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.reth.2022.09.001_bib69","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.reth.2022.09.001_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/currents.RRN1183","article-title":"Transplantation of patient-derived adipose stem cells in YAC128 Huntington's disease transgenic mice","volume":"2","author":"Im","year":"2010","journal-title":"PLoS Curr"},{"key":"10.1016\/j.reth.2022.09.001_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2017.00628","article-title":"Induced pluripotent stem cell-derived neural stem cell transplantations reduced behavioral deficits and ameliorated neuropathological changes in YAC128 mouse model of Huntington's disease","volume":"11","author":"Al-Gharaibeh","year":"2017","journal-title":"Front Neurosci"},{"key":"10.1016\/j.reth.2022.09.001_bib72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J\u00a0Comp Neurol"},{"key":"10.1016\/j.reth.2022.09.001_bib73","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.stemcr.2017.11.005","article-title":"Human neural stem cell transplantation rescues functional deficits in R6\/2 and Q140 huntington's disease mice","volume":"10","author":"Reidling","year":"2018","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.reth.2022.09.001_bib74","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/exnr.1998.6767","article-title":"Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze task","volume":"150","author":"Shear","year":"1998","journal-title":"Exp Neurol"},{"key":"10.1016\/j.reth.2022.09.001_bib75","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/stem.1135","article-title":"Neuronal properties, in\u00a0vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells","volume":"30","author":"Jeon","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.reth.2022.09.001_bib76","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/00207450390207759","article-title":"Autologous adult bone marrow stem cell transplantation in an animal model of huntington's disease: behavioral and morphological outcomes","volume":"113","author":"Lescaudron","year":"2003","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.reth.2022.09.001_bib77","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/exnr.1997.6657","article-title":"Generation and transplantation of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice","volume":"148","author":"Carpenter","year":"1997","journal-title":"Exp Neurol"},{"key":"10.1016\/j.reth.2022.09.001_bib78","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0149-7634(96)00027-9","article-title":"3-Nitropropionic acid animal model and Huntington's disease","volume":"21","author":"Borlongan","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.reth.2022.09.001_bib79","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbr.2010.11.006","article-title":"Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes","volume":"217","author":"Rossignol","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.reth.2022.09.001_bib80","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.nbd.2004.01.016","article-title":"Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease","volume":"16","author":"Ryu","year":"2004","journal-title":"Neurobiol Dis"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320422000876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320422000876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:38:48Z","timestamp":1762450728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320422000876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":80,"alternative-id":["S2352320422000876"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2022.09.001","relation":{},"ISSN":["2352-3204"],"issn-type":[{"value":"2352-3204","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis and potential therapeutic application of stem cells transplantation in Huntington\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2022.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}